Navigation Links
Ingenuity Systems Enhances Workflow for Experimental Transcriptome Analysis in Single Cells
Date:10/26/2009

REDWOOD CITY, Calif., Oct. 26 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced it has developed a new gene expression workflow with Life Technologies Corporation. The workflow leverages Ingenuity's IPA software and the Applied Biosystems SOLiD(TM) System and TaqMan® Gene Expression Assays and Arrays to open up new avenues for researchers to analyze and understand the transcriptome of individual cells, which is important for stem cell and disease research. Applied Biosystems is part of Life Technologies.

Scientists from Life Technologies and Ingenuity worked together to develop a joint workflow based on data published in a Nature Methods paper where whole transcriptome analysis using the SOLiD System was performed comparing wildtype single cells to those that had select genes "knocked out". Results were validated using TaqMan Assays for quantitative real-time PCR reactions. The team then used IPA to understand the functional impacts of this global gene expression disruption and to narrow in on key pathways and cellular processes. With this information, IPA helped the scientists create testable hypotheses for follow-up experiments using TaqMan Assays to validate transcript changes.

"One of our main objectives with IPA is to ensure that insights gained from gene expression profiles are used to help determine optimal follow-up experiments," said Peter DiLaura, Senior Vice President, Marketing and Products, Ingenuity Systems. "This joint workflow using the Applied Biosystems solutions and IPA helped researchers move from experiment to experiment by rapidly identifying relevant biological insights - such key mechanisms, functions, and pathways - and then providing a way to leverage those insights to design validation studies that help researchers better understand normal cellular and disease processes."

To learn more about this type of research, join Ingenuity and Life Technologies for free webinars on October 29th or November 3rd. Register here.

About IPA®

IPA is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. For more information visit: www.ingenuity.com

About Ingenuity Systems®

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com

SOURCE Ingenuity Systems


'/>"/>
SOURCE Ingenuity Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ingenuity and Integromics Offer Integration for Comprehensive Genomics Analysis
2. Ingenuity Systems Announces Multi-Year Deal With AstraZeneca
3. Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
4. Ingenuitys Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference
5. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
6. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
7. New Quick and Convenient Emergen-C(R) Shot Gives Immune Systems a Fighting Chance This Fall
8. IntraHealth to Lead $300 Million USAID Project in Global Health Workforce, Systems Strengthening
9. US Farms, Inc. Becomes a Registered Seller of Its Aloe365(TM) Skin Gel With Emergency Disaster Systems, Inc.
10. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
11. GTRI is developing protocols for testing effects of RFID systems on medical devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: